We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+16.51%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.31B
AUM Growth
+$63.1M
Cap. Flow
+$10.4M
Cap. Flow %
0.8%
Top 10 Hldgs %
44.12%
Holding
87
New
12
Increased
18
Reduced
18
Closed
37

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$36.9M
2
IRTC icon
iRhythm Holdings
IRTC
+$30.2M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$28.4M
4
PODD icon
Insulet
PODD
+$28.2M
5
PRVA icon
Privia Health
PRVA
+$23.3M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$90.9M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$19.8M
3
PRTA icon
Prothena Corp
PRTA
+$19.2M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$17.9M
5
MODN
MODEL N, INC.
MODN
+$17.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.53%
2 Industrials 2.52%
3 Communication Services 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
26
AnaptysBio
ANAB
$1.58B
$21.3M 1.63%
944,110
-293,068
-24% -$6.94M
SCTL
27
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$21.3M 1.63%
19,676,396
– –
OPRX icon
28
OptimizeRx
OPRX
$114M
$21.1M 1.62%
1,737,584
+10,286
+0.6% +$149K
ALPN
29
DELISTED
Alpine Immune Sciences Inc
ALPN
$19.9M 1.52%
+501,243
New +$14.8M
VERA icon
30
Vera Therapeutics
VERA
$2.3B
$18.8M 1.44%
+436,133
New +$15.5M
TNDM icon
31
Tandem Diabetes Care
TNDM
$1.34B
$16.8M 1.29%
475,077
+114,834
+32% +$3.08M
TELA icon
32
TELA Bio
TELA
$32.7M
$15.6M 1.2%
2,754,028
+199,387
+8% +$1.31M
IDYA icon
33
IDEAYA Biosciences
IDYA
$3.42B
$14.7M 1.13%
335,471
-10,203
-3% -$439K
KRMD icon
34
KORU Medical Systems
KRMD
$189M
$12.3M 0.94%
5,220,990
+57,253
+1% +$123K
PRTA icon
35
Prothena Corp
PRTA
$425M
$11M 0.84%
444,953
-643,848
-59% -$19.2M
NARI
36
DELISTED
Inari Medical, Inc. Common Stock
NARI
$10.3M 0.79%
+213,940
New +$11.4M
EVH icon
37
Evolent Health
EVH
$348M
$9.45M 0.72%
288,181
+206,459
+253% +$6.59M
PEN icon
38
Penumbra
PEN
$12.7B
$8.47M 0.65%
+37,955
New +$9.38M
THC icon
39
Tenet Healthcare
THC
$20.5B
$8.36M 0.64%
79,523
-115,077
-59% -$10.3M
INSM icon
40
Insmed
INSM
$21.4B
$7.67M 0.59%
282,766
-363,291
-56% -$10.2M
GPCR icon
41
Structure Therapeutics
GPCR
$3.41B
$6.39M 0.49%
+149,113
New +$6.29M
AXGN icon
42
Axogen
AXGN
$2.27B
$6.18M 0.47%
765,886
+489,397
+177% +$4.38M
LIVN icon
43
LivaNova
LIVN
$4.4B
$5.75M 0.44%
+102,792
New +$5.34M
HCAT icon
44
Health Catalyst
HCAT
$154M
$5.53M 0.42%
734,681
-279,794
-28% -$2.55M
PCVX icon
45
Vaxcyte
PCVX
$7.81B
$4.12M 0.32%
+60,284
New +$4.17M
GH icon
46
Guardant Health
GH
$21.7B
$3.91M 0.3%
189,765
+45,716
+32% +$980K
VTYX
47
DELISTED
Ventyx Biosciences
VTYX
$3.44M 0.26%
+624,842
New +$2.86M
DYN icon
48
Dyne Therapeutics
DYN
$4.7B
$3.01M 0.23%
+105,948
New +$2.4M
SLP icon
49
Simulations Plus
SLP
$369M
$1.18M 0.09%
28,741
-5,707
-17% -$234K
SONX
50
DELISTED
Sonendo, Inc.
SONX
$545K 0.04%
5,143,615
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, First Light Asset Management held 87 positions worth $1.31B, up 5.1% from $1.24B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

First Light Asset Management's Q1 2024 filing shows 12 new, 18 increased, 18 reduced and 37 closed positions. Its largest new stake was Centessa Pharmaceuticals: 3,002,045 shares worth $33.9M. The largest sale was Karuna Therapeutics, Inc. Common Stock, an estimated $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials and Communication Services.

  • First Light Asset Management's largest Q1 2024 buy was Centessa Pharmaceuticals: 3,002,045 shares worth $33.9M.
  • First Light Asset Management added most to Natera in Q1 2024, an estimated $36.9M increase.
  • First Light Asset Management's biggest Q1 2024 reduction was Prothena Corp, cutting an estimated $19.2M.
  • First Light Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $90.9M.
  • First Light Asset Management's ten largest holdings make up 44% of its $1.31B portfolio in Q1 2024.
  • First Light Asset Management opened 12 new positions and closed 37 in Q1 2024.
  • First Light Asset Management's portfolio value rose 5.1% quarter-over-quarter to $1.31B.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.